DPH3B expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 5.48679990330925E-10 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.21259999608503E-08 |
Normal-vs-Stage2 |
2.438700E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
3.123800E-02 |
Stage1-vs-Stage2 |
7.977800E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
3.874000E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
4.407200E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.06279999748205E-08 |
Normal-vs-AfricanAmerican |
1.246970E-01 |
Normal-vs-Asian |
1.085800E-01 |
Caucasian-vs-AfricanAmerican |
8.065400E-01 |
Caucasian-vs-Asian |
5.992600E-01 |
AfricanAmerican-vs-Asian |
4.076600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.811400E-04 |
Normal-vs-Female |
6.52860000505129E-08 |
Male-vs-Female |
6.066800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
5.355900E-03 |
Normal-vs-Extreme_Weight |
4.188300E-04 |
Normal-vs-Obese |
1.234310E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
3.042600E-01 |
Normal_Weight-vs-Obese |
1.302810E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
9.531600E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.61440002979896E-09 |
Normal-vs-Age(41-60Yrs) |
1.53044999999796E-05 |
Normal-vs-Age(61-80Yrs) |
1.385810E-04 |
Normal-vs-Age(81-100Yrs) |
1.990830E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.355540E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.191900E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.935200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.204000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.382200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.360400E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
8.978200E-01 |
Normal-vs-Grade 3 |
5.103400E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
1.223570E-01 |
Grade 2-vs-Grade 4 |
8.978200E-01 |
Grade 3-vs-Grade 4 |
5.103400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.08390005041315E-09 |
Normal-vs-N1 |
4.514100E-02 |
N0-vs-N1 |
2.020800E-01 |
|
|